MAS
IBB icon

Madden Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Madden Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,185
Closed -$774K – 70
2020
Q1 		$774K Hold
7,185
– – 0.54% 42
2019
Q4 		$865K Hold
7,185
– – 0.57% 45
2019
Q3 		$714K Sell
7,185
-535
-7% -$56K 0.51% 50
2019
Q2 		$842K Sell
7,720
-599
-7% -$63.7K 0.53% 47
2019
Q1 		$930K Hold
8,319
– – 0.5% 49
2018
Q4 		$802K Hold
8,319
– – 0.48% 50
2018
Q3 		$1.01M Hold
8,319
– – 0.61% 43
2018
Q2 		$913K Hold
8,319
– – 0.58% 43
2018
Q1 		$888K Sell
8,319
-150
-2% -$16.6K 0.54% 47
2017
Q4 		$904K Sell
8,469
-297
-3% -$31.7K 0.55% 45
2017
Q3 		$974K Hold
8,766
– – 0.62% 44
2017
Q2 		$906K Hold
8,766
– – 0.6% 45
2017
Q1 		$856K Hold
8,766
– – 0.55% 48
2016
Q4 		$775K Sell
8,766
-486
-5% -$44.2K 0.53% 52
2016
Q3 		$892K Sell
9,252
-2,040
-18% -$194K 0.55% 54
2016
Q2 		$968K Sell
11,292
-126
-1% -$11.3K 0.6% 51
2016
Q1 		$992K Sell
11,418
-225
-2% -$20.1K 0.65% 47
2015
Q4 		$1.31M Sell
11,643
-189
-2% -$20.5K 0.86% 39
2015
Q3 		$1.2M Buy
11,832
+1,578
+15% +$189K 0.78% 39
2015
Q2 		$1.26M Sell
10,254
-954
-9% -$114K 0.75% 43
2015
Q1 		$1.28M Sell
11,208
-1,269
-10% -$140K 0.77% 42
2014
Q4 		$1.26M Sell
12,477
-3,726
-23% -$362K 0.72% 44
2014
Q3 		$1.48M Buy
16,203
+81
+0.5% +$7.11K 0.77% 40
2014
Q2 		$1.38M Buy
16,122
+12
+0.1% +$945 0.7% 42
2014
Q1 		$1.27M Buy
16,110
+6,801
+73% +$567K 0.69% 43
2013
Q4 		$705K Buy
9,309
+4,620
+99% +$328K 0.53% 45
2013
Q3 		$328K Buy
4,689
+4,050
+634% +$265K 0.29% 60
2013
Q2 		$37K Buy
+639
New +$36.9K 0.03% 132

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Madden Advisory Services's IBB Position: Q2 2020 in Review

Madden Advisory Services sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 7,185 shares — an estimated $774K sold.

Madden Advisory Services first reported a position in IBB in Q2 2013 and held it in 28 quarters. The position peaked at $1.48M in Q3 2014. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

  • Madden Advisory Services reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
  • Madden Advisory Services sold 7,185 iShares Biotechnology ETF shares in Q2 2020, an estimated $774K.
  • Madden Advisory Services first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 28 quarters.
  • Madden Advisory Services's iShares Biotechnology ETF position peaked at $1.48M in Q3 2014.
  • 766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Madden Advisory Services's 13F filing for Q2 2020, filed 10 Aug 2020.